Overview / Abstract: |
Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions. STATEMENT OF NEED Oral mucositis (OM) is the inflammation of oral mucosa resulting from cancer therapy and manifesting as atrophy, swelling, erythema, and ulceration (Oronsky et al, 2018). Patients with OM may experience moderate-to-severe pain, difficulty speaking, difficulty eating and drinking, and ulcerations characterized by submucosal hemorrhaging and infection (Bolton, 2021). Due to these crippling effects, OM is considered one of the most debilitating toxicities of cancer therapy (Wilairat et al, 2020). TARGET AUDIENCE Nurses, nurse practitioners, and clinical nurse specialists. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: Describe the pathogenesis of oral mucositis |
Expiration |
Oct 17, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Credits / Hours |
1.0 NCPD | ILNA |
Accreditation |
ANCC |
Presenters / Authors / Faculty |
Lindsay Holden, RN, BSN, CCRN |
Sponsors / Supporters / Grant Providers |
i3 Health |
Keywords / Search Terms |
i3 Health i3 Health oncology, RCC, renal cell carcinoma, kidney cancer, CNE, NCPD, free CNE, free NCPD, ILNA points, free ILNA points, i3 Health, CE, free CE Free CE CME Free CE CME |